Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IMUX Stock Summary
In the News
IMUX Financial details
Company Rating
Neutral
Market Cap
129.5M
Income
-91.6M
Revenue
0
Book val./share
0.65
Cash/share
1.05
Dividend
-
Dividend %
-
Employees
77
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.36
Forward P/E
-
PEG
0.06
P/S
-
P/B
1.19
P/C
1.16
P/FCF
-0.81
Quick Ratio
3.46
Current Ratio
3.67
Debt / Equity
0.05
LT Debt / Equity
0.02
-
-
EPS (TTM)
-2.06
EPS next Y
-
EPS next Q
-
EPS this Y
-56.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-5.88%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
29.32%
Inst Trans
0.64%
ROA
-237%
ROE
-197%
ROC
-2.71%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.945-3.11
52W High
-
52W Low
-
RSI
43
Rel Volume
0.24
Avg Volume
654.16K
Volume
157.73K
Perf Week
-5.6%
Perf Month
-17.16%
Perf Quarter
11.72%
Perf Half Y
-0.99%
-
-
-
-
Beta
1.964
-
-
Volatility
0.07%, 0.07%
Prev Close
-4.86%
Price
1.2178
Change
-7.74%
IMUX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -4.51 | -2.81 | -3.92 | -4.85 | -2.11 | |
Operating cash flow per share | -3.7 | -2.94 | -3.52 | -2.05 | -1.6 | |
Free cash flow per share | -3.7 | -2.95 | -3.52 | -2.05 | -1.61 | |
Cash per share | 3.8 | 8.14 | 3.67 | 3.66 | 1.05 | |
Book value per share | 7.56 | 10.14 | 5.37 | 3.57 | 0.65 | |
Tangible book value per share | -0.98 | 5.93 | 2.59 | 3.57 | 0.65 | |
Share holders equity per share | 7.56 | 10.14 | 5.37 | 3.57 | 0.65 | |
Interest debt per share | 0.51 | 0.06 | 0.04 | 0.08 | 0.03 | |
Market cap | 74.91M | 239.5M | 226.36M | 44.55M | 66.48M | |
Enterprise value | 46.06M | 112.73M | 140.08M | -60.64M | 21.14M | |
P/E ratio | -2.15 | -5.45 | -2.44 | -0.29 | -0.71 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.62 | -5.19 | -2.72 | -0.68 | -0.94 | |
PFCF ratio | -2.62 | -5.18 | -2.72 | -0.68 | -0.93 | |
P/B Ratio | 1.28 | 1.51 | 1.78 | 0.39 | 2.3 | |
PTB ratio | 1.28 | 1.51 | 1.78 | 0.39 | 2.3 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -1.25 | -2.3 | -1.53 | 1.13 | -0.21 | |
EV to operating cash flow | -1.61 | -2.44 | -1.68 | 0.93 | -0.3 | |
EV to free cash flow | -1.61 | -2.44 | -1.68 | 0.93 | -0.3 | |
Earnings yield | -0.46 | -0.18 | -0.41 | -3.46 | -1.41 | |
Free cash flow yield | -0.38 | -0.19 | -0.37 | -1.46 | -1.07 | |
Debt to equity | 0.07 | 0.01 | 0.01 | 0.01 | 0.05 | |
Debt to assets | 0.06 | 0.01 | 0.01 | 0.01 | 0.02 | |
Net debt to EBITDA | 0.78 | 2.59 | 0.94 | 1.96 | 0.46 | |
Current ratio | 4.56 | 15.93 | 9.21 | 9.62 | 2.12 | |
Interest coverage | -346.09 | 0 | 0 | -114.78 | 0 | |
Income quality | 0.82 | 1.05 | 0.9 | 0.54 | 0.76 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.5 | 0.2 | 0.24 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -1.1 | -3.74 | -0.79 | -1.45 | -3.01 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 27.69 | 25.3 | 21.78 | 19.74 | 5.57 | |
ROIC | -0.59 | -0.3 | -0.71 | -1.32 | -3.21 | |
Return on tangible assets | -1.06 | -0.33 | -0.87 | -1.21 | -1.72 | |
Graham Net | 2.83 | 7.74 | 3.19 | 3.24 | 0.49 | |
Working capital | 25.16M | 125.35M | 93.59M | 112.79M | 27.81M | |
Tangible asset value | 25.39M | 125.82M | 94.15M | 113.68M | 28.93M | |
Net current asset value | 24.64M | 124.67M | 93M | 111.8M | 27.17M | |
Invested capital | 0.07 | 0.01 | 0.01 | 0.01 | 0.05 | |
Average receivables | 204K | 1.03M | 1.9M | 2.4M | 1.68M | |
Average payables | 1.35M | 3.06M | 3.72M | 4.01M | 4.69M | |
Average inventory | -204K | 1.5M | 633K | -2.4M | -1.33M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 17.69K | 34.63K | 16.08K | 20.29K | 16.77K | |
Days of inventory on hand | -2.98K | 31.97K | -9.23K | -12.59K | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
Inventory turnover | -0.12 | 0.01 | -0.04 | -0.03 | 0 | |
ROE | -0.6 | -0.28 | -0.73 | -1.36 | -3.24 | |
Capex per share | -0.01 | -0.01 | 0 | 0 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -2.78 | -0.53 | -0.54 | -0.51 | -0.48 | |
Operating cash flow per share | -0.47 | -0.45 | -0.45 | -0.39 | -0.31 | |
Free cash flow per share | -0.47 | -0.45 | -0.45 | -0.39 | -0.32 | |
Cash per share | 3.66 | 2.22 | 1.74 | 1.34 | 1.05 | |
Book value per share | 3.57 | 2.09 | 1.56 | 1.09 | 0.65 | |
Tangible book value per share | 3.57 | 2.09 | 1.56 | 1.09 | 0.65 | |
Share holders equity per share | 3.57 | 2.09 | 1.56 | 1.09 | 0.65 | |
Interest debt per share | 0.07 | 0 | 0.04 | 0.03 | 0.07 | |
Market cap | 44.55M | 65.06M | 111.53M | 65.52M | 66.95M | |
Enterprise value | -60.64M | -26.35M | 36.12M | 7.29M | 21.61M | |
P/E ratio | -0.13 | -0.7 | -1.16 | -0.72 | -0.78 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.95 | -3.33 | -5.58 | -3.78 | -4.77 | |
PFCF ratio | -2.95 | -3.32 | -5.58 | -3.78 | -4.72 | |
P/B Ratio | 0.39 | 0.71 | 1.61 | 1.35 | 2.31 | |
PTB ratio | 0.39 | 0.71 | 1.61 | 1.35 | 2.31 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 2.49 | 0.97 | -1.44 | -0.31 | -0.93 | |
EV to operating cash flow | 4.01 | 1.35 | -1.81 | -0.42 | -1.54 | |
EV to free cash flow | 4.01 | 1.34 | -1.81 | -0.42 | -1.52 | |
Earnings yield | -1.99 | -0.36 | -0.22 | -0.35 | -0.32 | |
Free cash flow yield | -0.34 | -0.3 | -0.18 | -0.26 | -0.21 | |
Debt to equity | 0.01 | 0.02 | 0.03 | 0.03 | 0.05 | |
Debt to assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Net debt to EBITDA | 4.32 | 3.35 | 3.02 | 2.47 | 1.94 | |
Current ratio | 9.62 | 6.54 | 4.74 | 3.67 | 2.12 | |
Interest coverage | -82.13 | 13.55 | 0 | 0 | -11.63 | |
Income quality | 0.27 | 0.77 | 0.83 | 0.76 | 0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.01 | 0 | 0 | 0.01 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0.05 | -3.25 | -0.95 | -1.29 | -7.17 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 14.96 | 5 | 4.35 | 3.53 | 2.66 | |
ROIC | -0.77 | -0.27 | -0.33 | -0.44 | -0.89 | |
Return on tangible assets | -0.69 | -0.21 | -0.27 | -0.34 | -0.4 | |
Graham Net | 3.37 | 1.84 | 1.41 | 0.98 | 0.49 | |
Working capital | 112.79M | 90.28M | 68.31M | 47.45M | 27.81M | |
Tangible asset value | 113.68M | 91.22M | 69.28M | 48.41M | 28.93M | |
Net current asset value | 111.8M | 88.93M | 67.1M | 46.66M | 27.17M | |
Invested capital | 0.01 | 0.02 | 0.03 | 0.03 | 0.05 | |
Average receivables | 3.02M | 3.16M | 3.86M | 2.93M | 1.25M | |
Average payables | 3.89M | 4.64M | 4.79M | 3.6M | 3.97M | |
Average inventory | 7.27M | 971K | 73K | 3.06M | 1.15M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 19.12K | 14.74K | 17.79K | 7.53K | 19.95K | |
Days of inventory on hand | 26.56K | -10.31K | 15.59K | 6.1K | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Inventory turnover | 0 | -0.01 | 0.01 | 0.01 | 0 | |
ROE | -0.78 | -0.26 | -0.35 | -0.47 | -0.75 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
IMUX Frequently Asked Questions
What is Immunic, Inc. stock symbol ?
Immunic, Inc. is a US stock , located in New york of Ny and trading under the symbol IMUX
What is Immunic, Inc. stock quote today ?
Immunic, Inc. stock price is $1.2178 today.
Is Immunic, Inc. stock public?
Yes, Immunic, Inc. is a publicly traded company.